LGC is an international life sciences measurement and testing company that operates in sustainably growing markets. It specializes in providing scientific testing, analytical, and diagnostic laboratory services across various sectors, including pharmaceuticals, agricultural biotechnology, food, environment, government, academic, security, and sports. LGC's offerings include reference materials, genomic analysis tools, and analytical testing products and services, all underpinned by its expertise in regulation, accreditation, and standard setting. The company focuses on delivering high-quality solutions that enhance innovation in nucleic acid therapies and cancer screening, with its products and services often integrated into customers' workflows to ensure ongoing value and performance.
Executive Vice President and General Manager of Corporate Development, Assure and NLS
Michael Sweatt
Executive Vice President and General Manager, Clinical Diagnostics
Kenneth Yoon Ph.D
Executive Vice President and General Manager of Diagnostics and Genomics
20 past transactions
DiaMex GmbH
Acquisition in 2024
DiaMex provides a comprehensive portfolio of Manufacturer-Independent Quality Controls, also called 3rd Party Controls.
Kova International
Acquisition in 2023
Kova International is a manufacturer specializing in quality control products and plastic assemblies for clinical diagnostic laboratories. The company focuses on urinalysis products tailored for the medical laboratory market, providing a range of sample collection tubes, caps, and slides specifically designed for urine dipstick chemistry, confirmatory and pregnancy tests, as well as microscopic urinalysis. Additionally, Kova International offers urine chemistry test strips and readers to facilitate microscopic sediment analysis, ensuring that laboratories have the necessary tools for accurate and efficient diagnostic testing.
Rapid Genomics
Acquisition in 2022
Rapid Genomics specializes in providing tailored genetic and genomic solutions aimed at enhancing agricultural efficiency. The company focuses on developing applications that improve the germplasm and breeding stock of crops and livestock, ultimately contributing to increased crop yields and healthier farm animals. Through its innovative technology, Rapid Genomics supports advancements in bioenergy, food production, and fiber generation, facilitating significant improvements in agricultural practices and genetic research. The overarching goal of the company is to foster a better quality of life through enhanced agricultural productivity and sustainability.
Technopath Clinical Diagnostics
Acquisition in 2021
Technopath Clinical Diagnostics specializes in the development and manufacturing of quality control materials and software for clinical laboratories. The company produces independent quality control products tailored for both in vitro and clinical diagnostic applications. Its software platform automates the management of quality control data, streamlining processes to meet laboratory accreditation requirements. By providing these products and services, Technopath aims to support clinical laboratories in achieving accurate and reliable diagnostic results.
MBH Analytical
Acquisition in 2018
MBH Analytical Ltd, based in Barnet, United Kingdom, specializes in the manufacture and supply of certified reference materials for spectroscopic and spectrochemical analysis. Established in 1973, the company has become a significant player in the global market, providing over 1,400 reference materials following its acquisition by LGC Limited in December 2018. MBH Analytical's product offerings include metal alloy reference materials, peristaltic pump tubing, viscometer tubes, and a variety of ferrous and non-ferrous substances, catering to industries such as metallurgical testing, foundries, and automotive sectors. The company’s materials are utilized in laboratories around the world, and it also has the capability to source additional materials through established networks if not produced in-house.
SeraCare
Acquisition in 2018
SeraCare Life Sciences, Inc. is a provider of products and services that support the discovery, development, and production of diagnostics and therapeutics for both human and animal health. The company operates in two main segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic segment offers controls, panels, and reagents for infectious disease testing and drug development, including cell culture additives and therapeutic grade albumin. The BioServices segment provides biorepository, sample processing, and testing services for research and clinical trials, along with contract research support in areas such as molecular biology and biochemistry. SeraCare's clientele includes laboratories, blood banks, pharmaceutical and biotechnology companies, as well as government and academic institutions, primarily in the United States, Europe, and Asia. Established in 1984 and headquartered in Milford, Massachusetts, SeraCare operates as a subsidiary of LGC Standards Ltd.
Berry & Associates
Acquisition in 2018
Berry & Associates, Inc., based in Dexter, Michigan, specializes in the production of stable isotope labeled nucleosides and phosphoramidites, along with a diverse range of specialty oligo reagents. Founded in 1989, the company has established itself as a premier supplier in the field, employing a dedicated team of 14 individuals. In 2015, Berry & Associates expanded its product offerings through the acquisition of Icon Isotopes, enhancing its capabilities in stable isotope research compounds and gases. The company develops a comprehensive portfolio of nearly 200 phosphoramidites and solid phase-linked monomers. Its products serve various sectors, including contract manufacturing organizations, pharmaceuticals, clinical diagnostics, and academic research, often collaborating with universities to further advance its innovative solutions. As of September 2018, Berry & Associates operates as a subsidiary of LGC Limited.
BioAutomation Systems
Acquisition in 2018
Since 1999, BioAutomation has served the biotechnology industry with automation solutions to assist in research and development. Their strength is their ability to design, deliver and service solutions that are tailored to their customers applications. Their oligonucleotide synthesizers provide scientists and researchers in the biotech field specialized tools capable of adapting to changing requirements. These products come in a variety of configurations to serve the needs of their customers.
Lucigen
Acquisition in 2018
Lucigen Corporation specializes in providing products and services for DNA and RNA cloning, sequencing, amplification, and protein expression. Founded in 1998 and based in Middleton, Wisconsin, the company offers a wide range of solutions, including long mate pair library kits, DNA sample preparation kits, and various cloning and expression kits. Its product lineup features PCR solutions, competent cells, and a variety of enzymes, such as polymerases. Lucigen also supplies cloning kits and vectors, as well as accessory kits designed to facilitate various laboratory processes. Additionally, the company provides genome closure services and genomic technologies to support life science researchers in their work. Lucigen operates as a subsidiary of LGC Limited since 2018.
Link Technologies
Acquisition in 2017
Link Technologies Ltd. specializes in the custom and contract manufacturing of specialty products for oligonucleotides. The company provides a wide range of reagents for the synthesis and modification of DNA, RNA, LNA, and PNA, including modified nucleosides, nucleotides, and various phosphoramidites. It also produces solvents, solid supports for DNA and RNA synthesis, and peptide nucleic acids. Additionally, Link Technologies offers services such as reverse synthesis, backbone modification, and bioconjugation, along with analytical methods and product testing. Its clientele includes commercial and academic researchers working in gene sequencing, gene therapy, diagnostics, and molecular biology. Founded in 1989 and based in Bellshill, United Kingdom, Link Technologies operates as a subsidiary of LGC Limited.
Axolabs
Acquisition in 2017
Axolabs GmbH is a preclinical research organization based in Kulmbach, Germany, specializing in nucleic acid therapeutics, particularly oligonucleotide therapeutics. Founded in 2007 and previously known as Roche Kulmbach GmbH, the company offers a comprehensive range of services tailored to meet specific client needs, including oligonucleotide synthesis, analytics, pharmacology, target validation, and assessment of delivery technologies. Additionally, Axolabs provides consultancy services and conducts preclinical research and development. With over a decade of experience, Axolabs leverages its expertise to support clients throughout the drug discovery process and is known for its strategic alliance with Arrowhead Research Corp. The company operates as a subsidiary of LGC Limited, enhancing its capabilities in the evolving field of nucleic acid-based therapies.
API Food Quality
Acquisition in 2017
API Food Quality, known for its innovative solutions and technical excellence, offered the world’s first accredited proficiency testing program for six non-O157 Shiga toxin-producing E. coli (STEC) adulterants. Among the largest proficiency testing providers globally, it serves over 1,000 food laboratories in 30 countries.
BRC Global Standards
Acquisition in 2016
BRC Global Standards is a leading provider of safety and quality standards programs for the food industry, covering manufacturing, packaging, storage, and distribution. With over 24,000 certified suppliers across 130 countries, BRC Global Standards offers a globally recognized certification that ensures adherence to quality, safety, and operational criteria. Through an accredited network of certification bodies, BRC Global Standards helps manufacturers meet legal requirements and ensures consumer protection throughout the supply chain.
Prime Synthesis
Acquisition in 2016
Prime Synthesis, Inc. is a developer and manufacturer of DNA synthesis materials tailored for the biomedical research sector. Established in 1988, the company specializes in producing Controlled Pore Glass (CPG) supports and ancillary reagents essential for oligonucleotide synthesis. Its core offerings include reagent kits, CE phosphoramidites, oligo purification products, and molecular traps. Based in Aston, Pennsylvania, Prime Synthesis operates a 20,000 square foot facility that houses administrative offices, production areas, and research laboratories. The organization has established partnerships with local universities, granting access to advanced microscopy and spectroscopy equipment and a network of specialists in biomedical, chemistry, and materials science. In 2016, Prime Synthesis was acquired by LGC, enhancing its capabilities within the genomics field and integrating additional technical expertise into its product offerings.
o2si smart solutions
Acquisition in 2016
o2si smart solutions, LLC, based in Charleston, South Carolina, specializes in the manufacture of organic and inorganic reference standards tailored for various industries, including environmental, petroleum, clinical, food, industrial hygiene, and pharmaceuticals. Founded in 1997, the company focuses on providing custom calibration standards with competitive pricing and quick turnaround times. Its product offerings encompass a wide range of organic standards, such as volatile and semi-volatile organic mixes, pesticide and PCB mixes, as well as single component and custom organic solutions. In addition, o2si supplies inorganic standards, including ion chromatography standards, metalorganic standards, and both single and multi-element inorganic solutions. The company's commitment to technical excellence and superior customer service has positioned it as a leader in the environmental standards sector, with a growing presence in innovative laboratory products and specialty reagents. o2si distributes its products globally through a network of distributors.
Douglas Scientific
Acquisition in 2016
Douglas Scientific LLC, based in Alexandria, Minnesota, specializes in designing and manufacturing advanced laboratory instruments and automation solutions. Established in 2009 as a division of Douglas Machine Inc and incorporated in 2010, the company offers patented Array Tape technology, a continuous polymer strip with micro wells that enables rapid processing of genetic samples and chemical compounds. Its product portfolio includes high-throughput instruments such as IntelliQube, Soellex, Nexar, and Araya, which enhance liquid handling, thermal cycling, and assay processing. Douglas Scientific's innovations support various fields, including plant genomics, animal health, human diagnostics, and pharmaceuticals, allowing scientists to conduct screening efficiently and cost-effectively. The company has experienced significant growth and employs over 100 professionals with expertise in engineering and biosciences, contributing to its mission of advancing scientific research and discovery.
Maine Standards Company
Acquisition in 2015
Maine Standards Company is the provider of calibration verification materials for clinical laboratories.
Thistle QA
Acquisition in 2015
Thistle QA is a proficiency testing service provider located in Bryanston, South Africa. The company offers a comprehensive range of over 35 proficiency testing schemes, catering to various sectors and ensuring participants meet industry standards. By delivering these specialized services, Thistle QA supports organizations in evaluating and enhancing their testing processes, ultimately contributing to improved quality and reliability in their operations.
Biosearch Technologies
Acquisition in 2015
Biosearch Technologies, Inc. is a Petaluma, California-based company specializing in the design and manufacture of nucleic acid-based products that enhance genomic research and applications. Founded in 1993, the company offers a diverse range of products, including ValuPanel Reagents for research, Stellaris RNA FISH probes for detecting and quantifying individual mRNA molecules in fixed samples, and custom oligonucleotides. Additionally, Biosearch provides fluorogenic probes, primers, and labeling reagents for post-synthesis applications in DNA, proteins, and peptides. Their product offerings also include immunochemicals and various conjugates. Biosearch Technologies markets its products through a network of distributors both in the United States and internationally, and it is ISO 9001:2008 certified, reflecting its commitment to quality in its manufacturing processes.
HFL Sport Science
Acquisition in 2010
HFL Sport Science is the world’s largest independent provider of drug surveillance, doping control and research activities to human and equine sports. The acquisition of HFL will extend and complement LGC’s current analytical service offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.